Teclas de Ayuda de acceso Rápido

ALT + 1 Inicio

ALT + 2 Noticias

ALT + 3 Mapa de sitio

ALT + 4 Búsqueda

ALT + 5 Preguntas frecuentes

ALT + 6 Atención al ciudadano

ALT + 7 Quejas y reclamos

ALT + 8 Iniciar Sesión

ALT + 9 Directorio telefónico

Botones de Accesibilidad

Letra:

Contraste:

Esp
domingo, 28 de noviembre 2021
28/11/2021
Síguenos

Fichas

Research group

Spanish

Pharmacology and Toxicology Research Group INFARTO

Academic Unit: Faculty of Medicine

Colombian Ministry of Science

Class

B

Call

833

Profile

OECD

Discipline

Medical and health sciences

Subdiscipline

Health sciences

Download get_app

Strategic Focus

We aim to become the leading group in Latin America within the next five years in clinical and pharmacological research in topics such as economic evaluation of medicines and health technologies, respiratory diseases, and clinical toxicology.

Research Areas and Topics

  • Pharmacoeconomics.
  • Pharmacoepidemiology.
  • Pharmacogenetics
  • Respiratory Diseases.

Sustainable Development Goals (SDGs)

Good health and well-being

Group Coordinator

Jefferson Antonio Buendía Rodríguez, MD, M.Sc., Ph.D.

Ph.D. in Pharmacy and Biochemistry.

Universidad de Buenos Aires, Argentina.

Group Coordinator Email

jefferson.buendia@udea.edu.co

Scientific Cooperation

Collaborative Relationships

  • Academic networks with Infant Foundation, Vanderbilt University.
  • Respira: Respiratory Diseases in Children Study Group Universidad Nacional de Colombia.
  • Central Military Hospital, Pediatric Pneumology Section.

Notable Projects

  • Comparison of four pharmacological strategies aimed to prevent the lung inflammation and paraquat-induced alveolar damage.
  • Costs of Respiratory Syncytial Virus Hospitalizations in Colombia.
  • Combinational Effect of CYP3A5 and MDR-1 Polymorphisms on Tacrolimus Pharmacokinetics in Liver Transplant Patients.
  • Cost-effectiveness of diagnostic strategies of severe bacterial infection in infants with fever without a source.
  • Development of an antifibrotic scaffold platform mediator of tissue regeneration as therapeutic approach for the endomyocardial fibrosis treatment in the Department of Antioquia. General Royalties System.
  • Colombian Ministry of Science.

Main Research Results

  • Costs of Respiratory Syncytial Virus Hospitalizations in Colombia, DOI: 10.1007/s41669-020-00218-7
  • Risk factors associated with pulmonary exacerbations in pediatric patients with cystic fibrosis. DOI: 10.5546/aap.2019.eng.e466
  • Comparison of four pharmacological strategies aimed to prevent the lung inflammation and paraquat-induced alveolar damage. DOI: 10.1186/s13104-019-4598-0

Research Portafolio

  • Advisory and training in health technology assessment.

 

More information

More Information

https://bit.ly/3tTOidC

 
Universidad de Antioquia | Vigilada Mineducación | Acreditación institucional hasta el 2022 | NIT 890980040-8
Recepción de correspondencia: calle 70 No. 52 - 21 | Apartado Aéreo 1226 | Dirección: calle 67 No. 53 - 108 | Horario de atención
Conmutador: [57 + 604] 219 8332 | Línea gratuita de atención al ciudadano: 018000 416384 | Fax: [57 + 604] 263 8282
Peticiones, quejas, reclamos, sugerencias, denuncias, consultas y felicitaciones
Política de tratamiento de datos personales
Medellín - Colombia | Todos los Derechos Reservados © 2020